As of 2025-12-16, the Relative Valuation of Mersana Therapeutics Inc (MRSN) is (243.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.59 USD, the upside of Mersana Therapeutics Inc based on Relative Valuation is -953.0%.
The range of the Relative Valuation is (171.84) - (285.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 20.4x | 17.3x |
| Forward P/E multiples | 12.3x - 24.8x | 17.5x |
| Fair Price | (171.84) - (285.65) | (243.88) |
| Upside | -701.0% - -1099.1% | -953.0% |
| Date | P/E |
| 2025-12-15 | -2.04 |
| 2025-12-12 | -2.02 |
| 2025-12-11 | -2.01 |
| 2025-12-10 | -2.01 |
| 2025-12-09 | -2.01 |
| 2025-12-08 | -1.99 |
| 2025-12-05 | -1.98 |
| 2025-12-04 | -1.96 |
| 2025-12-03 | -1.99 |
| 2025-12-02 | -1.96 |
| 2025-12-01 | -1.96 |
| 2025-11-28 | -1.96 |
| 2025-11-26 | -1.96 |
| 2025-11-25 | -1.96 |
| 2025-11-24 | -1.95 |
| 2025-11-21 | -1.95 |
| 2025-11-20 | -1.96 |
| 2025-11-19 | -1.97 |
| 2025-11-18 | -1.96 |
| 2025-11-17 | -1.98 |
| 2025-11-14 | -1.99 |
| 2025-11-13 | -1.96 |
| 2025-11-12 | -0.63 |
| 2025-11-11 | -0.64 |
| 2025-11-10 | -0.61 |
| 2025-11-07 | -0.60 |
| 2025-11-06 | -0.57 |
| 2025-11-05 | -0.60 |
| 2025-11-04 | -0.58 |
| 2025-11-03 | -0.67 |
| 2025-10-31 | -0.68 |
| 2025-10-30 | -0.66 |
| 2025-10-29 | -0.68 |
| 2025-10-28 | -0.73 |
| 2025-10-27 | -0.76 |
| 2025-10-24 | -0.70 |
| 2025-10-23 | -0.70 |
| 2025-10-22 | -0.66 |
| 2025-10-21 | -0.72 |
| 2025-10-20 | -0.74 |
| 2025-10-17 | -0.70 |
| 2025-10-16 | -0.75 |
| 2025-10-15 | -0.75 |
| 2025-10-14 | -0.73 |
| 2025-10-13 | -0.71 |
| 2025-10-10 | -0.66 |
| 2025-10-09 | -0.65 |
| 2025-10-08 | -0.67 |
| 2025-10-07 | -0.57 |
| 2025-10-06 | -0.59 |